{"public_id":"co_c30e3e36aa9805c693a4cd5303488b1c","status":"active","merged_into_public_id":null,"resolved_public_id":"co_c30e3e36aa9805c693a4cd5303488b1c","name":"BRAF","description":"A melanoma subtype defined by activating alterations in the BRAF gene.","aliases":[],"types":["disease subtype"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":32430993,"title":"Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines.","citation_count":66,"url":"https://sah.borca.ai/papers/32430993"}],"claims":[{"public_id":"cl_607d07a0074fb9e36ca991b724abe9b0","text":"Models representing all previously reported major melanoma subtypes were identified, including BRAF, NRAS, NF1, KIT, and WT/WT/WT.","corpus_id":32430993,"url":"https://sah.borca.ai/claims/cl_607d07a0074fb9e36ca991b724abe9b0"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_c30e3e36aa9805c693a4cd5303488b1c","url":"https://sah.borca.ai/concepts/co_c30e3e36aa9805c693a4cd5303488b1c"}